BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24837972)

  • 1. A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas.
    Schneider M; Cremer HJ; Ruef P
    Acta Paediatr; 2014 Sep; 103(9):977-83. PubMed ID: 24837972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
    Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
    Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propranolol therapy for periocular and orbital infantile haemangiomas].
    Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
    Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
    Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
    Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
    Moodley ST; Hudson DA; Adams S; Adams KG
    Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propranolol-resistant infantile haemangiomas.
    Caussé S; Aubert H; Saint-Jean M; Puzenat E; Bursztejn AC; Eschard C; Mahé E; Maruani A; Mazereeuw-Hautier J; Dreyfus I; Miquel J; Chiaverini C; Boccara O; Hadj-Rabia S; Stalder JF; Barbarot S;
    Br J Dermatol; 2013 Jul; 169(1):125-9. PubMed ID: 23659587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
    Phillips RJ; Penington AJ; Bekhor PS; Crock CM
    J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol was effective in treating cutaneous infantile haemangiomas in Thai children.
    Techasatian L; Komwilaisak P; Panombualert S; Uppala R; Jetsrisuparb C
    Acta Paediatr; 2016 Jun; 105(6):e257-62. PubMed ID: 26919396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
    Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
    Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol in the management of periorbital infantile haemangioma.
    Cheng JF; Gole GA; Sullivan TJ
    Clin Exp Ophthalmol; 2010 Aug; 38(6):547-53. PubMed ID: 20553300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of propranolol in the treatment of childhood haemangiomas of the head and neck.
    Goswamy J; Rothera MP; Bruce IA
    J Laryngol Otol; 2011 Nov; 125(11):1164-72. PubMed ID: 21846414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.
    Dyme JL; Thampan A; Han EJ; Nyirenda TL; Kotb ME; Shin HT
    Cardiol Young; 2012 Aug; 22(4):424-9. PubMed ID: 22166728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
    Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
    Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of infantile haemangiomas of the orbit with propranolol.
    Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
    Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infantile haemangioma: an update].
    Reimer A; Ott H
    Hautarzt; 2019 Jun; 70(6):447-458. PubMed ID: 31101924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids as an adjunct to propranolol for infantile haemangiomas complicated by recalcitrant ulceration.
    Lie E; Püttgen KB
    Br J Dermatol; 2017 Apr; 176(4):1064-1067. PubMed ID: 27479792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rapid regression of infantile haemangioma with 2% propranolol ointment].
    Mouhari-Toure A; Azoumah KD; Tchamdja K; Saka B; Kombaté K; Tchangaï-Walla K; Pitche P
    Ann Dermatol Venereol; 2013; 140(6-7):462-4. PubMed ID: 23773747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for recalcitrant ulcerated hemangioma of infancy.
    Hong E; Fischer G
    Pediatr Dermatol; 2012; 29(1):64-7. PubMed ID: 21854419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of propranolol in infantile haemangioma among Chinese children.
    Chik KK; Luk CK; Chan HB; Tan HY
    Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.